Performant Healthcare, Inc.
PHLT
$7.62
-$0.015-0.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 28.75% | 21.71% | 6.75% | 5.20% | 15.21% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.75% | 21.71% | 6.75% | 5.20% | 15.21% |
| Cost of Revenue | 9.33% | 9.20% | 14.60% | 12.99% | 13.01% |
| Gross Profit | 127.40% | 92.34% | -12.99% | -20.47% | 27.89% |
| SG&A Expenses | -- | -- | 50.00% | -50.00% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 10.17% | -3.40% | 18.16% | 2.29% | 2.62% |
| Total Operating Expenses | 9.53% | 5.96% | 15.66% | 9.98% | 10.37% |
| Operating Income | 196.32% | 103.83% | -136.04% | -230.62% | 23.88% |
| Income Before Tax | 181.81% | 98.98% | -170.00% | -140.02% | 24.60% |
| Income Tax Expenses | 2,150.00% | 150.00% | -1,692.00% | 103.69% | -23.81% |
| Earnings from Continuing Operations | 169.36% | 97.98% | -139.68% | -311.03% | 24.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 169.36% | 97.98% | -139.68% | -311.03% | 24.59% |
| EBIT | 196.32% | 103.83% | -136.04% | -230.62% | 23.88% |
| EBITDA | 599.64% | 163.50% | -79.81% | -134.53% | 64.81% |
| EPS Basic | 167.87% | 98.08% | -139.26% | -303.95% | 25.76% |
| Normalized Basic EPS | 180.17% | 99.08% | -169.23% | -134.57% | 25.77% |
| EPS Diluted | 166.00% | 98.08% | -163.19% | -207.00% | 23.66% |
| Normalized Diluted EPS | 178.10% | 99.08% | -169.90% | -134.57% | 25.77% |
| Average Basic Shares Outstanding | 2.09% | 1.81% | 1.83% | 1.69% | 1.61% |
| Average Diluted Shares Outstanding | 4.88% | 1.81% | 1.21% | 1.69% | 1.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |